The winter freeze didn't dim the Burmese python population in Florida but the drought may mean new challenges to hunters in ...

MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The large series of programming changes will put some familiar faces in new ...

Add Yahoo as a preferred source to see more of our stories on Google. MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee, and has a ...

Cell phone bans in schools are working—at least as far as keeping kids off their phones during school, according to a new working paper. But the bans, which have been touted by researchers, educators ...

April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it ‌would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Researchers at ...

A new study suggests a substance in python blood could lead to new weight loss therapies for humans. The mice given the substance lost 9% of their body weight over 28 days. Scientists believe this ...

CU Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy. The ...

Elia projected, "On a projected basis, we anticipate suitable for robust assessment of VYD2311 effectiveness if the clinical performance of VYD2311 matches our modeling and prior experience with COVID ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...